J. Jeffrey Marshall

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

D Hunt, George Varigos, F Dienstl et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1992 · 898 citations

Thrombosis, Cardiovascular Disease, Cardiology +8

Off-Pump vs Conventional Coronary Artery Bypass Grafting: Early and 1-Year Graft Patency, Cost, and Quality-of-Life Outcomes

John D. Puskas, Willis H. Williams, Elizabeth M. Mahoney et al. · JAMA · 2004 · 568 citations

Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative

Mir B. Basir, Navin K. Kapur, Kirit Patel et al. · Catheterization and Cardiovascular Interventions · 2019 · 442 citations

Safety and Feasibility of Robotic Percutaneous Coronary Intervention

Giora Weisz, D. Christopher Metzger, Ronald Caputo et al. · Journal of the American College of Cardiology · 2013 · 297 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Patient Safety +5

Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients

John D. Puskas, Vinod H. Thourani, J. Jeffrey Marshall et al. · The Annals of Thoracic Surgery · 2001 · 241 citations

Percutaneous Coronary Intervention, Resource Utilization, Health Policy +13